Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001980402 | SCV002274453 | uncertain significance | Renal carnitine transport defect | 2021-08-31 | criteria provided, single submitter | clinical testing | This sequence change replaces tyrosine with cysteine at codon 492 of the SLC22A5 protein (p.Tyr492Cys). The tyrosine residue is highly conserved and there is a large physicochemical difference between tyrosine and cysteine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with SLC22A5-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC22A5 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Giacomini Lab, |
RCV001980402 | SCV002576694 | uncertain significance | Renal carnitine transport defect | 2022-10-03 | criteria provided, single submitter | research |